In this episode,  Adam Torres and Robert Schultz, Founder and CEO of Sollievo Pharmaceuticals, Inc., explore Sollievo Pharmaceutical's new treatment. The company is developing a novel rapid-acting sedative to treat violent patients in the Emergency Department.

Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule.

Apply to be interviewed by Adam on our podcast:
https://missionmatters.lpages.co/podcastguest/

More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia

Learn more about your ad choices. Visit podcastchoices.com/adchoices